Resveratrol, a phytoestrogen found in red wine, down-regulates protein S expression in HepG2 cells

Thrombosis Research

Volumn 127, Issue 1, 2011, Pages

  Hiroto, Yoshie ^a   Tadokoro, Kana ^a   Tsuda, Tomohide ^b   Nakazono, Eri ^a   Ohnaka, Keizo ^c   Takayanagi, Ryoichi ^c   Hamasaki, Naotaka ^d   Tsuda, Hiroko ^a  

^a NAKAMURA GAKUEN UNIVERSITY   (Japan)

^b SHINO TEST CORPORATION   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d NAGASAKI INTERNATIONAL UNIVERSITY   (Japan)

Author keywords

HepG2 cells; Phytoestrogen; Protein C anticoagulant pathway; Protein S; Resveratrol

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CALPHOSTIN C; COMPLEMENT COMPONENT C4B BINDING PROTEIN; DAIDZEIN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; GENISTEIN; LUCIFERASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PICEATANNOL; PROTEIN C; PROTEIN S; RESVERATROL;

ARTICLE; CELL CULTURE; CELL LEVEL; CELL SECRETION; CELL STRAIN HEPG2; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; QUANTITATIVE ANALYSIS; RED WINE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STRUCTURE ACTIVITY RELATION; TRANSIENT TRANSFECTION; WESTERN BLOTTING;

BLOOD PROTEINS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESTROGEN RECEPTOR ALPHA; GENE EXPRESSION REGULATION, NEOPLASTIC; GENISTEIN; HEP G2 CELLS; HISTOCOMPATIBILITY ANTIGENS; HUMANS; LIVER NEOPLASMS; MOLECULAR STRUCTURE; PHYTOESTROGENS; PROMOTER REGIONS, GENETIC; PROTEIN C; PROTEIN S; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; WINE;

EID: 78650512503     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.09.010     Document Type: Article

References (40)

1. M. Takaoka Resveratrol, a new phenolic compound, from Veratrum grandiflorum Nippon Kagaku Kaishi 60 1939 1090 1100 [Japanese]
2. D.K. Das, and N. Maulik Resveratrol in cardioprotection: a therapeutic promise of alternative medicine Mol Interv 6 2006 36 47
3. S. Pervaiz, and A.L. Holme Resveratrol: its biologic targets and functional activity Antioxid Redox Signal 11 2009 2851 2897
4. P. Moutsatsou The spectrum of phytoestrogens in nature: our knowledge is expanding Hormones (Athens) 6 2007 173 193
5. B.D. Gehm, J.M. McAndrews, P.Y. Chien, and J.L. Jameson Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor Proc Natl Acad Sci USA 94 1997 14138 14143
6. J.L. Bowers, V.V. Tyulmenkov, S.C. Jernigan, and C.M. Klinge Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta Endocrinology 141 2000 3657 3667
7. D.M. Goldberg, E. Tsang, A. Karumanchiri, E. Diamandis, G. Soleas, and E. Ng Method to assay the concentrations of phenolic constituents of biological interest in wines Anal Chem 68 1996 1688 1694
8. S. Renaud, and M. de Lorgeril Wine, alcohol, platelets, and the French paradox for coronary heart disease Lancet 339 1992 1523 1526
9. M. Jang, L. Cai, G.O. Udeani, K.V. Slowing, C.F. Thomas, and C.W. Beecher Cancer chemopreventive activity of resveratrol, a natural product derived from grapes Science 275 1997 218 220
10. K.T. Howitz, K.J. Bitterman, H.Y. Cohen, D.W. Lamming, S. Lavu, and J.G. Wood Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan Nature 425 2003 191 196
11. J.G. Wood, B. Rogina, S. Lavu, K. Howitz, S.L. Helfand, and M. Tatar Sirtuin activators mimic caloric restriction and delay ageing in metazoans Nature 430 2004 686 689
12. J.A. Baur, K.J. Pearson, N.L. Price, H.A. Jamieson, C. Lerin, and A. Kalra Resveratrol improves health and survival of mice on a high-calorie diet Nature 444 2006 337 342
13. S.M. Rezende, R.E. Simmonds, and D.A. Lane Coagulation, inflammation, and apoptosis: different roles for protein S and the protein S-C4b binding protein complex Blood 103 2004 1192 1201
14. B. Dahlback Advances in understanding pathogenic mechanisms of thrombophilic disorders Blood 112 2008 19 27
15. M.J. Heeb, R.M. Mesters, G. Tans, J. Rosing, and J.H. Griffin Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C J Biol Chem 268 1993 2872 2877
16. T.M. Hackeng, K.M. Sere, G. Tans, and J. Rosing Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor Proc Natl Acad Sci USA 103 2006 3106 3111
17. S. Gandrille, D. Borgel, N. Sala, Y. Espinosa-Parrilla, R. Simmonds, and S. Rezende Protein S deficiency: a database of mutations-summary of the first update Thromb Haemost 84 2000 918
18. S. Kinoshita, H. Iida, S. Inoue, K. Watanabe, M. Kurihara, and Y. Wada Protein S and protein C gene mutations in Japanese deep vein thrombosis patients Clin Biochem 38 2005 908 915
19. R. Kimura, S. Honda, T. Kawasaki, H. Tsuji, S. Madoiwa, and Y. Sakata Protein S-K196E mutation as a genetic risk factor for deep vein thrombosis in Japanese patients Blood 107 2006 1737 1738 (Pubitemid 43242422)
20. F.R. Rosendaal Venous thrombosis: the role of genes, environment, and behavior Hematology Am Soc Hematol Educ Program 2005 1 12
21. H. Tsuda, M. Urata, T. Tsuda, M. Wakiyama, H. Iida, and M. Nakahara Four missense mutations identified in the protein S gene of thrombosis patients with protein S deficiency: effects on secretion and anticoagulant activity of protein S Thromb Res 105 2002 233 239
22. H. Tatewaki, H. Tsuda, T. Kanaji, K. Yokoyama, and N. Hamasaki Characterization of the human protein S gene promoter: a possible role of transcription factors Sp1 and HNF3 in liver Thromb Haemost 90 2003 1029 1039
23. T. Tsuda, H. Tsuda, H. Yoshimura, and N. Hamasaki Dynamic equilibrium between protein S and C4b binding protein is important for accurate determination of free protein S antigen Clin Chem Lab Med 40 2002 563 567
24. H. Yokoi, S. Natsuyama, M. Iwai, Y. Noda, T. Mori, and K.J. Mori Non-radioisotopic quantitative RT-PCR to detect changes in mRNA levels during early mouse embryo development Biochem Biophys Res Commun 195 1993 769 775
25. Y.K. Hodges, L. Tung, X.D. Yan, J.D. Graham, K.B. Horwitz, and L.D. Horwitz Estrogen receptors alpha and beta: prevalence of estrogen receptor beta mRNA in human vascular smooth muscle and transcriptional effects Circulation 101 2000 1792 1798
26. W.C. Hooper, D.J. Phillips, M. Ribeiro, J. Benson, and B.L. Evatt IL-6 upregulates protein S expression in the HepG-2 hepatoma cells Thromb Haemost 73 1995 819 824
27. T. Burstyn-Cohen, M.J. Heeb, and G. Lemke Lack of protein S in mice causes embryonic lethal coagulopathy and vascular dysgenesis J Clin Invest 119 2009 2942 2953
28. D.S. Fair, and R.A. Marlar Biosynthesis and secretion of factor VII, protein C, protein S, and the Protein C inhibitor from a human hepatoma cell line Blood 67 1986 64 70
29. A. Suzuki, N. Sanda, Y. Miyawaki, Y. Fujimori, T. Yamada, and A. Takagi Down-regulation of PROS1 gene expression by 17beta-estradiol via estrogen receptor alpha (ERalpha)-Sp1 interaction recruiting receptor-interacting protein 140 and the corepressor-HDAC3 complex J Biol Chem 285 2010 13444 13453
30. H.L. Yang, W.Q. Chen, X. Cao, A. Worschech, L.F. Du, and W.Y. Fang Caveolin-1 enhances resveratrol-mediated cytotoxicity and transport in a hepatocellular carcinoma model J Transl Med 7 2009 22
31. G.A. Potter, L.H. Patterson, E. Wanogho, P.J. Perry, P.C. Butler, and T. Ijaz The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1 Br J Cancer 86 2002 774 778
32. A.M. Brzozowski, A.C. Pike, Z. Dauter, R.E. Hubbard, T. Bonn, and O. Engstrom Molecular basis of agonism and antagonism in the oestrogen receptor Nature 389 1997 753 758
33. A.C. Pike, A.M. Brzozowski, R.E. Hubbard, T. Bonn, A.G. Thorsell, and O. Engstrom Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist EMBO J 18 1999 4608 4618
34. M. Maggiolini, A.G. Recchia, D. Bonofiglio, S. Catalano, A. Vivacqua, and A. Carpino The red wine phenolics piceatannol and myricetin act as agonists for estrogen receptor alpha in human breast cancer cells J Mol Endocrinol 35 2005 269 281
35. M.C. Haigis, and D.A. Sinclair Mammalian sirtuins: biological insights and disease relevance Annu Rev Pathol 5 2010 253 295
36. D.M. Goldberg, J. Yan, and G.J. Soleas Absorption of three wine-related polyphenols in three different matrices by healthy subjects Clin Biochem 36 2003 79 87
37. M. Iwasaki, M. Inoue, T. Otani, S. Sasazuki, N. Kurahashi, and T. Miura Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from the Japan Public Health Center-based prospective study group J Clin Oncol 26 2008 1677 1683
38. T. Usui Pharmaceutical prospects of phytoestrogens Endocr J 53 2006 7 20
39. J.A. Baur, and D.A. Sinclair Therapeutic potential of resveratrol: the in vivo evidence Nat Rev Drug Discov 5 2006 493 506
40. D.R. Rios, E.T. Rodrigues, A.P. Cardoso, M.B. Montes, S.A. Franceschini, and M.R. Toloi Effects of isoflavones on the coagulation and fibrinolytic system of postmenopausal women Nutrition 24 2008 120 126